{{Rsnum
|rsid=10502675
|Gene=PM20D1
|Chromosome=18
|position=37618333
|Orientation=plus
|GMAF=0.2622
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 46.9 | 42.5 | 10.6
| HCB | 67.6 | 29.4 | 2.9
| JPT | 63.7 | 33.6 | 2.7
| YRI | 41.1 | 44.5 | 14.4
| ASW | 48.2 | 35.7 | 16.1
| CHB | 67.6 | 29.4 | 2.9
| CHD | 71.6 | 24.8 | 3.7
| GIH | 49.5 | 38.6 | 11.9
| LWK | 40.9 | 47.3 | 11.8
| MEX | 61.4 | 38.6 | 0.0
| MKK | 35.3 | 44.9 | 19.9
| TSI | 34.3 | 54.9 | 10.8
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=22952603
  |Trait=Response to amphetamines
  |Title=Genome-wide association study of d-amphetamine response in healthy volunteers identifies putative associations, including cadherin 13 (CDH13).
  |RiskAllele=
  |Pval=3E-6
  |OR=NR
  |ORtxt=NR
  |OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | Illumina Human 1M}}